VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

H.R. 2802 · 109th Congress

Drug Testing Integrity Act of 2005

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 109th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

EED EngelSponsor
4 cosponsors · 3 D, 1 R

0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to…

What it does: CRS summary · Introduced in House · Jun 8, 2005

Drug Testing Integrity Act of 2005 - Declares it is unlawful to: (1) knowingly manufacture, market, sell, ship, or otherwise provide to another individual any product with the intent to assist the use of such product to defraud a drug test (that is, to submit a substance that purports to be from an individual other than its actual source, or purports to have been excreted or collected other than when it was actually excreted or collected); or (2) engage in any other conduct with the intent to produce a false or misleading outcome of a test for the presence of a controlled substance.

Grants the Federal Trade Commission enforcement powers as a violation of an unfair or deceptive act or practice.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Drug Testing Integrity Act of 2005

Latest action (Jun 17, 2005): Referred to the Subcommittee on Commerce, Trade and Consumer Protection.

Policy area: Crime and Law Enforcement · Origin: House · Introduced: Jun 8, 2005

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.